EFS Event free survival
OS Osteosarcoma
MAP Methotrexate, Adriamycin (doxorubicin), cisplatin
HR Hazards-ratio
SOC Standard of care
LC Local control
MIOS Multi Institutional Osteosarcoma Study
MAPIE Methotrexate, Adriamycin (doxorubicin), cisplatin, ifosfamide, etoposide